Suchergebnisse - "Sarilumab"

PubPharm (319)

41

A Woman with Rheumatoid Arthritis Who Successfully Delivered a Healthy Child with Continuous Administration of Sarilumab Throughout Pregnancy

enthalten in: Internal medicine (Tokyo, Japan) | 2023

von Mizutani, S. | Okunishi, Y. | Tamada, T. | +7

42

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

enthalten in: Rheumatology and therapy | 2023

von Huizinga, T. | Choy, E. | Praestgaard, A. | +8

43

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

enthalten in: Rheumatology and therapy | 2023

von Huizinga, T. | Choy, E. | Praestgaard, A. | +8

44

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

enthalten in: Rheumatology and therapy | 2023

von Huizinga, T. | Choy, E. | Praestgaard, A. | +8

45

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gallagher, J. | Morgan, R.

CommentOn: Clin Microbiol Infect. 2023 Jan;29(1):13-21. - PMID 35863630

46

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids : a systematic review and meta-analysis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Albuquerque, A. | Eckert, I. | Tramujas, L. | +4

CommentIn: Clin Microbiol Infect. 2023 Jan;29(1):7-9. - PMID 36257548

47

Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients

enthalten in: Cancer control : journal of the Moffitt Cancer Center | 2023

von Velez, A. | Handley, G. | Morison, A. | +5

48

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages

in: International Journal of Infectious Diseases | 2023

von Maaike C. Swets | Rob J. Moss | Flip Kor | +10

49

Interleukin-6 and Macular Edema: A Review of Outcomes with Inhibition

in: International Journal of Molecular Sciences | 2023

von Janine Yunfan Yang | David Goldberg | Lucia Sobrin

50

Sarilumab is not Inferior to Tocilizumab in the Treatment of Cytokine Release Syndrome in COVID-19

in: Российский журнал гастроэнтерологии, гепатологии, колопроктологии | 2023

von V. T. Ivashkin | R. V. Maslennikov | E. V. Vasilieva | +4